1. Home
  2. EBMT vs MDWD Comparison

EBMT vs MDWD Comparison

Compare EBMT & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Bancorp Montana Inc.

EBMT

Eagle Bancorp Montana Inc.

HOLD

Current Price

$20.90

Market Cap

163.1M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.92

Market Cap

193.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBMT
MDWD
Founded
1922
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.1M
193.3M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
EBMT
MDWD
Price
$20.90
$16.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$23.00
$36.00
AVG Volume (30 Days)
63.3K
70.7K
Earning Date
04-28-2026
05-20-2026
Dividend Yield
2.82%
N/A
EPS Growth
53.23
N/A
EPS
1.90
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$48.88
Revenue Next Year
$5.00
$35.08
P/E Ratio
$10.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.11
$14.14
52 Week High
$23.75
$22.51

Technical Indicators

Market Signals
Indicator
EBMT
MDWD
Relative Strength Index (RSI) 49.08 51.56
Support Level $15.93 $16.68
Resistance Level $23.04 $18.71
Average True Range (ATR) 0.67 0.77
MACD 0.05 -0.00
Stochastic Oscillator 59.93 74.95

Price Performance

Historical Comparison
EBMT
MDWD

About EBMT Eagle Bancorp Montana Inc.

Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: